Ignite Creation Date:
2024-05-06 @ 3:55 PM
Last Modification Date:
2024-10-26 @ 1:59 PM
Study NCT ID:
NCT04801628
Status:
UNKNOWN
Last Update Posted:
2021-03-17
First Post:
2021-03-11
Brief Title:
Immediate Effects of TECAR Therapy on the Quadriceps Muscle Performance in Athlete A Randomized Crossover Trial
Sponsor:
Cairo University
Organization:
Cairo University
Study Overview
Official Title:
Immediate Effects of TECAR Therapy on the Quadriceps Muscle Performance in Athlete
Status:
UNKNOWN
Status Verified Date:
2021-02
Last Known Status:
ENROLLING_BY_INVITATION
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The experimental procedures will be composed of two sessions The following steps will be constituted the first session warm-up on the cycle ergometer and familiarization with the isokinetic dynamometer then baseline measurement of isokinetic parameters Afterward the placebo or active TECAR therapy will be applied according to the randomization At the end isokinetic parameters will be taken again After 7 days the second session will be performed following identical procedures to the first session However an inverse mode of TECAR therapy from the first session placebo or active will be applied for each individual The two sessions will be held 7 days apart either on a Sunday or Tuesday Procedures are summarized in Figure 1 The dominant lower limb test will be used to elect the lower limb selected for isokinetic Dynamometer
Figure 1 Timeline for the period of evaluation of groups Active and Placebo TECAR
Muscle performance measurement by Isokinetic Dynamometer
The quadriceps muscles of dominant lower limb will be tested for all participants with Biodex isokinetic dynamometer Biodex Medical System Shiley NY USA linked to IBM PC-computer software Calibration of the Biodex for torque and angular speed will be done according to the prescribed manufacturers guidelines before each recording session Prior to assessment the volunteers held a 5-min cycle ergometer warm up speed in the range of 60-70 rpm and no load After that participants will be positioned with hip angle of 100o on the previously calibrated isokinetic dynamometer and will be properly aligned and stabilized with straps in order to avoid possible compensatory movements Thus the dominant knee axis lateral epicondyle of the femur of each subject was adjusted to the dynamometer rotation axis The lever arm of the equipment was fixed approximately 2 cm above the tibial malleolus The chair height backrest distance seat angle and dynamometer base were adjusted for each subject and noted for the second session Before starting the recording of isokinetic muscle performance there will be a familiarization period with the apparatus consisting of five submaximal voluntary concentric muscle contractions in the full range of standardized and preprogrammed motion 90-20 according to the guideline procedures of the dynamometer with a constant angular velocity of 180s the isokinetic protocol will be performed with a set of 60 concentriceccentric contractions of quadriceps The participants will be visually and verbally encouraged throughout the test protocol to achieve maximum effort from the beginning The muscle performance in terms of work fatigue index peak torque average power and total work of the knee extensor muscles will be evaluated by isokinetic dynamometry in accordance with the guidelines of the equipment manufacturer Biodex Medical System Inc
Experimental protocol of TECAR therapy
Immediately after the baseline measurement of muscle performance of each session the participants will be received placebo or active TECAR therapy
In this experiment Transfer Electrode Capacitive and Resistive TECAR Therapy radio frequency therapy INDIBA Spain will be used TECAR therapy is a systematic treatment for providing capacitive energy transfer CET and resistive energy transfer RET In CET mode heat transfer is concentrated on the skin and superficial muscles which are tissue with high electrolytes while the RET mode focuses heat transfer on bones tendons joints and deep muscles In this study both CET and RET modes will be applied to the participant quadriceps for 15-20 minutes at stable frequency of 448 KHz According to the manufacturers guidelines for safety the CET mode will be first implemented for 5 minutes Then will be continued in RET mode using for the rest of the treatment Participants will be asked to lie down comfortably and treatment will be beginning
The intensity of the current will be set at the level of comfort between 0-100 averaging about 40 TECAR therapy will be applied by a physical therapist for all participants
Figure 1 Timeline for the period of evaluation of groups Active and Placebo TECAR
Muscle performance measurement by Isokinetic Dynamometer
The quadriceps muscles of dominant lower limb will be tested for all participants with Biodex isokinetic dynamometer Biodex Medical System Shiley NY USA linked to IBM PC-computer software Calibration of the Biodex for torque and angular speed will be done according to the prescribed manufacturers guidelines before each recording session Prior to assessment the volunteers held a 5-min cycle ergometer warm up speed in the range of 60-70 rpm and no load After that participants will be positioned with hip angle of 100o on the previously calibrated isokinetic dynamometer and will be properly aligned and stabilized with straps in order to avoid possible compensatory movements Thus the dominant knee axis lateral epicondyle of the femur of each subject was adjusted to the dynamometer rotation axis The lever arm of the equipment was fixed approximately 2 cm above the tibial malleolus The chair height backrest distance seat angle and dynamometer base were adjusted for each subject and noted for the second session Before starting the recording of isokinetic muscle performance there will be a familiarization period with the apparatus consisting of five submaximal voluntary concentric muscle contractions in the full range of standardized and preprogrammed motion 90-20 according to the guideline procedures of the dynamometer with a constant angular velocity of 180s the isokinetic protocol will be performed with a set of 60 concentriceccentric contractions of quadriceps The participants will be visually and verbally encouraged throughout the test protocol to achieve maximum effort from the beginning The muscle performance in terms of work fatigue index peak torque average power and total work of the knee extensor muscles will be evaluated by isokinetic dynamometry in accordance with the guidelines of the equipment manufacturer Biodex Medical System Inc
Experimental protocol of TECAR therapy
Immediately after the baseline measurement of muscle performance of each session the participants will be received placebo or active TECAR therapy
In this experiment Transfer Electrode Capacitive and Resistive TECAR Therapy radio frequency therapy INDIBA Spain will be used TECAR therapy is a systematic treatment for providing capacitive energy transfer CET and resistive energy transfer RET In CET mode heat transfer is concentrated on the skin and superficial muscles which are tissue with high electrolytes while the RET mode focuses heat transfer on bones tendons joints and deep muscles In this study both CET and RET modes will be applied to the participant quadriceps for 15-20 minutes at stable frequency of 448 KHz According to the manufacturers guidelines for safety the CET mode will be first implemented for 5 minutes Then will be continued in RET mode using for the rest of the treatment Participants will be asked to lie down comfortably and treatment will be beginning
The intensity of the current will be set at the level of comfort between 0-100 averaging about 40 TECAR therapy will be applied by a physical therapist for all participants
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None